Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Chan

Showing results (201-210 of 271) with videos related to

Pageof 28
Sort By:
Cancer Cell|August 15, 2018
Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal LandscapesIan Ganly, Vladimir Makarov, Shyamprasad Deraje, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2021
Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell CarcinomaKyrollis Attalla, Renzo G DiNatale, Phillip M Rappold, et al.
Nature Communications|November 1, 2017
Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusionsMartin G Dalin, Nora Katabi, Marta Persson, et al.
European Urology Focus|December 10, 2019
Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical CourseRenzo G DiNatale, Alexander N Gorelick, Vladimir Makarov, et al.
The Journal of Clinical Investigation|February 7, 2020
Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapyJing Li, Weichao Wang, Yajia Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2017
Transcriptional Mechanisms of Resistance to Anti-PD-1 TherapyMaria L Ascierto, Alvin Makohon-Moore, Evan J Lipson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2009
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancersSelvaraju Veeriah, Cameron Brennan, Shasha Meng, et al.
Nature Cancer|January 2, 2026
Intratumoral bacteria are immunosuppressive and promote immunotherapy resistance in head and neck squamous cell carcinomaNatalie L Silver, Jin Dai, Travis D Kerr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2020
The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal MelanomasAlvin P Makohon-Moore, Evan J Lipson, Jody E Hooper, et al.
Immunity|October 26, 2022
Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancerBriana G Nixon, Fengshen Kuo, LiangLiang Ji, et al.
Pageof 28

Showing results (201-210 of 271) with videos related to

Sort By:
Pageof 28
Cancer Cell|August 15, 2018
Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal LandscapesIan Ganly, Vladimir Makarov, Shyamprasad Deraje, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2021
Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell CarcinomaKyrollis Attalla, Renzo G DiNatale, Phillip M Rappold, et al.
Nature Communications|November 1, 2017
Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusionsMartin G Dalin, Nora Katabi, Marta Persson, et al.
European Urology Focus|December 10, 2019
Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical CourseRenzo G DiNatale, Alexander N Gorelick, Vladimir Makarov, et al.
The Journal of Clinical Investigation|February 7, 2020
Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapyJing Li, Weichao Wang, Yajia Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2017
Transcriptional Mechanisms of Resistance to Anti-PD-1 TherapyMaria L Ascierto, Alvin Makohon-Moore, Evan J Lipson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2009
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancersSelvaraju Veeriah, Cameron Brennan, Shasha Meng, et al.
Nature Cancer|January 2, 2026
Intratumoral bacteria are immunosuppressive and promote immunotherapy resistance in head and neck squamous cell carcinomaNatalie L Silver, Jin Dai, Travis D Kerr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2020
The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal MelanomasAlvin P Makohon-Moore, Evan J Lipson, Jody E Hooper, et al.
Immunity|October 26, 2022
Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancerBriana G Nixon, Fengshen Kuo, LiangLiang Ji, et al.
Pageof 28